Free Trial

Salesforce (CRM) Stock Forecast & Price Target

Salesforce logo
$273.05 -10.37 (-3.66%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$273.00 -0.05 (-0.02%)
As of 05/23/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Salesforce - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
6
Buy
36

Based on 43 Wall Street analysts who have issued ratings for Salesforce in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 43 analysts, 1 has given a sell rating, 6 have given a hold rating, 31 have given a buy rating, and 5 have given a strong buy rating for CRM.

Consensus Price Target

$351.59
28.76% Upside
According to the 43 analysts' twelve-month price targets for Salesforce, the average price target is $351.59. The highest price target for CRM is $450.00, while the lowest price target for CRM is $200.00. The average price target represents a forecasted upside of 28.76% from the current price of $273.05.
Get the Latest News and Ratings for CRM and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Salesforce and its competitors.

Sign Up

CRM Analyst Ratings Over Time

TypeCurrent Forecast
5/25/24 to 5/25/25
1 Month Ago
4/25/24 to 4/25/25
3 Months Ago
2/25/24 to 2/24/25
1 Year Ago
5/26/23 to 5/25/24
Strong Buy
5 Strong Buy rating(s)
5 Strong Buy rating(s)
4 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
31 Buy rating(s)
31 Buy rating(s)
31 Buy rating(s)
23 Buy rating(s)
Hold
6 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
9 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$351.59$351.37$375.53$310.94
Forecasted Upside28.76% Upside31.17% Upside21.82% Upside14.19% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CRM Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRM Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Salesforce Stock vs. The Competition

TypeSalesforceComputer and Technology CompaniesS&P 500
Consensus Rating Score
2.93
2.65
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside28.76% Upside120.99% Upside16.40% Upside
News Sentiment Rating
Positive News

See Recent CRM News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/23/2025Citigroup
3 of 5 stars
T. Radke
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetNeutral ➝ Neutral$335.00 ➝ $320.00+14.36%
5/22/2025UBS Group
3 of 5 stars
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$350.00+23.64%
5/15/2025Mizuho
3 of 5 stars
Gregg Moskowitz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$425.00 ➝ $380.00+30.85%
4/30/2025Westpark Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Curtis Shauger
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00 ➝ $320.00+19.50%
4/25/2025Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Scott Berg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$400.00 ➝ $400.00+51.35%
4/23/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Carter Gould
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$210.00-17.77%
4/23/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Bracelin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$400.00 ➝ $315.00+24.73%
4/22/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Turrin
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$310.00 ➝ $255.00+8.03%
4/21/2025Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Difucci
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Neutral
4/21/2025DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Gil Luria
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Underperform$200.00-19.01%
4/16/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$405.00 ➝ $393.00+56.80%
3/31/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brent Thill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$425.00 ➝ $375.00+43.23%
3/20/2025Macquarie
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Beynon
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$320.00 ➝ $320.00+14.67%
3/19/2025BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform
3/19/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brett Huff
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageEqual Weight$311.00+11.48%
3/17/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Verkhovski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetSector Outperform ➝ Sector Outperform$400.00 ➝ $345.00+23.43%
2/27/2025Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Yun Kim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetHold ➝ Hold$330.00 ➝ $300.00+0.80%
2/27/2025Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$415.00 ➝ $400.00+34.40%
2/27/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Parker Lane
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$425.00 ➝ $375.00+24.79%
2/27/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Rob Oliver
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$430.00 ➝ $400.00+30.21%
2/27/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brian Schwartz
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$415.00 ➝ $380.00+23.70%
2/27/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Brad Sills
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$440.00 ➝ $400.00+30.21%
2/19/2025Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
O. Sheikh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
1/17/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Derrick Wood
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$380.00 ➝ $400.00+24.62%
12/18/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Outperform ➝ Market Outperform$450.00 ➝ $450.00+27.15%
12/18/2024Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$425.00 ➝ $425.00+21.08%
12/13/2024KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ader
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSector Weight ➝ Overweight$440.00+22.84%
12/4/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$340.00 ➝ $380.00+3.28%
12/4/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$300.00 ➝ $420.00+16.53%
12/4/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$360.00 ➝ $400.00+8.54%
12/4/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$380.00 ➝ $400.00+20.57%
12/4/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$415.00 ➝ $425.00+28.10%
12/4/2024Northland Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$400.00 ➝ $440.00+32.62%
11/19/2024Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy
10/17/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Aaron Siegel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Target$343.00+16.88%
10/2/2024Northland Capmk
Subscribe to MarketBeat All Access for the recommendation accuracy rating
N. Chokshi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/30/2024Phillip Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Accumulate$305.00+20.72%
8/29/2024FBN Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seyrafi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Slowinski
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/29/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$234.00 ➝ $236.00-8.87%
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.

Click here to see how you could take a stake in Elon’s private company…
8/29/2024Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$335.00 ➝ $335.00+28.58%
8/29/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$325.00 ➝ $350.00+35.19%
8/26/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00+13.39%
5/30/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$350.00 ➝ $300.00+39.82%
4/16/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$365.00+33.82%
3/6/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$290.00 ➝ $354.00+16.46%
9/15/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$267.00+22.04%
6/1/2023Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Baldry
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
6/1/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:17 PM ET.


Should I Buy Salesforce Stock? CRM Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, May 24, 2025. Please send any questions or comments about these Salesforce pros and cons to contact@marketbeat.com.

Salesforce
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Salesforce, Inc.:

  • The current stock price is around $283, which is significantly lower than its 1-year high of $369, potentially offering a buying opportunity for investors looking for value.
  • Salesforce, Inc. has a strong market capitalization of approximately $272.15 billion, indicating a robust position in the market and the ability to invest in growth opportunities.
  • With a consensus rating of "Moderate Buy" from analysts, including a significant number of buy ratings, there is positive sentiment surrounding the stock's future performance.
  • The company maintains a low debt-to-equity ratio of 0.14, suggesting financial stability and lower risk associated with debt, which can be attractive to conservative investors.
  • Recent insider trading activity shows that executives are actively managing their positions, which can indicate confidence in the company's future prospects.

Salesforce
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Salesforce, Inc. for these reasons:

  • Salesforce, Inc. has experienced a decline in stock price from its recent highs, which may raise concerns about its short-term performance and market volatility.
  • The company has seen significant insider selling, with insiders selling over 46,000 shares recently, which could signal a lack of confidence in the stock's near-term prospects.
  • Despite a strong market position, the stock has a high P/E ratio of 46.56, indicating that it may be overvalued compared to its earnings, which could deter value-focused investors.
  • Analysts have varying price targets, with some reducing their expectations, which may create uncertainty about the stock's future price trajectory.
  • Institutional ownership is high at 80.43%, which can lead to increased volatility if large investors decide to sell their positions quickly.

CRM Forecast - Frequently Asked Questions

According to the research reports of 43 Wall Street equities research analysts, the average twelve-month stock price forecast for Salesforce is $351.59, with a high forecast of $450.00 and a low forecast of $200.00.

43 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Salesforce in the last twelve months. There is currently 1 sell rating, 6 hold ratings, 31 buy ratings and 5 strong buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CRM shares.

According to analysts, Salesforce's stock has a predicted upside of 28.76% based on their 12-month stock forecasts.

Over the previous 90 days, Salesforce's stock had 3 upgrades by analysts.

Analysts like Salesforce more than other "computer and technology" companies. The consensus rating score for Salesforce is 2.93 while the average consensus rating score for "computer and technology" companies is 2.65. Learn more on how CRM compares to other companies.


This page (NYSE:CRM) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners